{"ModuleTitle": "Company Description", "CompanyName": "Endologix, Inc.", "Symbol": "ELGX", "Address": "2 MUSICK, IRVINE, California, 92618, United States of America", "Phone": "9495984741", "Industry": "Medical/Dental Instruments", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "We develop, manufacture, market and sell innovative medical devices for the\r\ntreatment of aortic disorders. Our products are intended for the minimally\r\ninvasive endovascular treatment of abdominal aortic aneurysms (\"AAA\"). Our AAA\r\nproducts are built on one of two platforms:\r\n* Traditional minimally-invasive endovascular aneurysm repair (\"EVAR\"); or\r\n\r\n\r\n*            Endovascular aneurysm sealing (\"EVAS\"), our innovative solution for \r\n             sealing the aneurysm sac while maintaining blood flow.              \r\n\r\n\r\nOur current EVAR products include the AFX\u00ae Endovascular AAA System (the \"AFX\r\nSystem\"), the VELA\u00ae Proximal Endograft (\"VELA\") and the Ovation\u00ae Abdominal Stent\r\nGraft System (the \"Ovation System\"). Our current EVAS product is the Nellix\u00ae\r\nEndovascular Aneurysm Sealing System (the \"Nellix EVAS System\").&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f03%2f11%2f0001013606-20-000026.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Elisa Hebb", "title": "Vice President-Clinical & Regulatory Affairs"}, {"name": "Jeffrey S. Brown", "title": "Chief Operating Officer"}, {"name": "John Onopchenko", "title": "Chief Executive Officer & Director"}, {"name": "Matthew Thompson", "title": "Chief Medical Officer"}, {"name": "Michael V. Chobotov", "title": "Chief Technology Officer"}, {"name": "Vaseem Mahboob", "title": "Chief Financial & Accounting Officer"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}